Made-in-Vietnam COVID-19 vaccine to begin human trial from December 10
Vietnam will conduct the first phase of human trials of a locally made COVID-19 vaccine from December 10, Minister of Health Nguyen Thanh Long said at a meeting with Vietnamese vaccine producers on December 5.
Minister of Health Nguyen Thanh Long (standing) at the meeting with Vietnamese vaccine producers on December 5 (Photo: VNA).
Hanoi (VNA) - Vietnam will conduct the first phase of human trialsof a locally made COVID-19 vaccine from December 10, Minister of Health NguyenThanh Long said at a meeting with Vietnamese vaccine producers on December 5.
To date, Vietnamese producers have worked to accelerate the research of COVID-19vaccines, with Ivac, Vabiotech and Nanogen completing production process atlaboratory scale and currently evaluating the vaccines’ safety and immunity inanimals. Meanwhile, Nanogen is now ready to pilot the first phase of humantrial.
Nanogen will join hands with the Military Medical University to recruitvolunteers for the first phase of clinical trial on December 10.
At the meeting, experts and vaccine producers discussed progress of vaccine productionand challenges during vaccine development, as well as outline solutions for thetime ahead.
Laying stress on the significance of COVID-19 vaccine production, Long said theministry has promoted domestic research and production while enhancing cooperation withinternational vaccine developers so as to gain early access to vaccine sources.
He urged localvaccine producers to speed up their work in order to launch human trial soon, and pledged support for the producers, including minimising administrativeprocedures and facilitating product registration and licensing.
The Ministry of Health will work with competent agencies to help producers getaccess to capital for vaccine development and production, he added.
Long requested vaccine producer Polivac to continue with its research on COVID-19 vaccine,while coordinating with Russia and China to leverage access to vaccine suppliers in the two nations./.
Vietnam recorded no new COVID-19 case on December 4, keeping the national tally at 1,361, according to the National Steering Committee on COVID-19 Prevention and Control.
By harnessing the will and power of each nation and strengthening solidarity and cooperation, the international community will win the battle against COVID-19, Prime Minister Nguyen Xuan Phuc said in his message to the UN General Assembly’s special session on COVID-19 response.
Vietnam recorded four new COVID-19 cases from 6pm of December 4 to 6pm of December 5, all Vietnamese and imported, bringing the national tally to 1,365, according to the National Steering Committee on COVID-19 Prevention and Control.
Hanoi authorities on December 5 recorded two coronavirus-positive patients, including a man who again tested positive for the SARS-CoV-2 after being discharged from hospital in Dong Da district, and a diplomat entering Vietnam and under stay-at-home quarantine in Bac Tu Liem district.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.